Show simple item record

dc.rights.licenseCreative Commons Attribution 4.0 International License
dc.contributor.authorGheorghe, Adrianen
dc.contributor.authorZaman, Rashid Uzen
dc.contributor.authorScott, Mollyen
dc.contributor.authorWitter, Sophieen
dc.date.accessioned2019-02-05T15:41:28Z
dc.date.available2019-02-05T15:41:28Z
dc.date.issued2018-12-04
dc.identifier.citationGheorghe, A., Zaman, R. Scott, M. & Witter, S. (2018) Delivering reproductive health services through non-state providers in Pakistan: Understanding the value for money of different approaches. Global Health Research & Policy, 3 [33].en
dc.identifier.issn2397-0642en
dc.identifier.urihttps://eresearch.qmu.ac.uk/handle/20.500.12289/9252
dc.identifier.urihttps://doi.org/10.1186/s41256-018-0089-4
dc.descriptionSophie Witter - orcid: 0000-0002-7656-6188 https://orcid.org/0000-0002-7656-6188en
dc.description.abstractBackground - Delivering Reproductive Health Results(DRHR) programme used social franchising (SF) and social marketing (SM) approaches to increase the supply of high quality family planning services in underserved areas of Pakistan. We assessed the costs, cost-efficiency and cost-effectiveness of DRHR to understand the value for money of these approaches.en
dc.description.abstractMethods - Financial and economic programme costs were calculated. Costs to individual users were captured in a pre-post survey. The cost per couple years of protection (CYP) and cost per new user were estimated as indicators of cost efficiency. For the cost-effectiveness analysis we estimated the cost per clinical outcome averted and the cost per disability-adjusted life year (DALY) averted.
dc.description.abstractResults - Approximately £20 million were spent through the DRHR programme between July 2012 and September 2015 on commodities and services representing nearly four million CYPs. Based on programme data, the cumulative cost-efficiency of the entire DRHR programme was £4.8 per CYP. DRHR activities would avert one DALY at the cost of £20. Financial access indicators generally improved in programme areas, but the magnitude of progress varies across indicators.
dc.description.abstractConclusions - The SF and SM approaches adopted in DRHR appear to be cost effective relative to comparable reproductive health programmes. This paper adds to the limited evidence on the cost-effectiveness of different models of reproductive health care provision in low- and middle-income settings. Further studies are needed to nuance the understanding of the determinants of impact and value for money of SF and SM.
dc.description.sponsorshipThis study was funded by UKaid from the UK government. However, the views expressed do not necessarily reflect the UK government’s official policies.en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.ispartofGlobal Health Research & Policyen
dc.rights© The Author(s) 2018.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectReproductive Healthen
dc.subjectSocial Franchising (SF)en
dc.subjectSocial Marketing (SM)en
dc.subjectValue for Moneyen
dc.subjectPakistanen
dc.subjectNon-state Providersen
dc.titleDelivering reproductive health services through non-state providers in Pakistan: Understanding the value for money of different approachesen
dc.typeArticleen
dcterms.accessRightspublic
dcterms.dateAccepted2018-11-05
dc.description.volume3 [33]en
dc.description.ispublishedpub
rioxxterms.typeJournal Article/Reviewen
refterms.dateFCA2019-02-05
refterms.dateFCD2019-02-05
refterms.depositExceptionpublishedGoldOAen
refterms.accessExceptionNAen
refterms.technicalExceptionNAen
refterms.panelUnspecifieden
qmu.authorWitter, Sophieen
qmu.centreInstitute for Global Health and Developmenten
dc.description.statuspub
refterms.versionVoRen
refterms.dateDeposit2019-02-05


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International License
Except where otherwise noted, this item's license is described as Creative Commons Attribution 4.0 International License